Immunohistochemical Expression of Activated Caspase-3 as a Marker of Apoptosis in Glomeruli of Human Lupus Nephritis

American Journal of Kidney Diseases

Volumn 48, Issue 3, 2006, Pages 410-418

  Jeruc, Jera ^a   Vizjak, Alenka ^a   Rozman, Blaž ^a   Ferluga, Dušan ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Apoptosis; caspase 3; inflammation; kidney; lupus nephritis

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CREATININE; DNA ANTIBODY; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DNA BINDING; ENZYME ACTIVATION; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BIOPSY; KIDNEY CELL; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NICK END LABELING; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; CASPASES; CHILD; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUPUS NEPHRITIS; MALE; MIDDLE AGED;

EID: 33747609826     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.05.019     Document Type: Article

References (36)

1. Mene P., and Amore A. Apoptosis. Potential role in renal diseases. Nephrol Dial Transplant 13 (1998) 1936-1943
2. Baker A.J., Mooney A., Huges J., Lombardi D., Johnson R.J., and Savill J. Mesangial cell apoptosis. The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94 (1994) 2105-2116
3. Shimizu A., Kitamura H., Masuda Y., Ishizaki M., Sugisaki Y., and Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47 (1995) 114-121
4. Shimizu A., Masuda Y., Kitamura H., Ishizaki M., Sugisaki Y., and Yamanaka N. Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 74 (1996) 941-951
5. Sugiyama H., Kashihara N., Makino H., Yamasaki Y., and Ota A. Apoptosis in glomerular sclerosis. Kidney Int 49 (1996) 103-111
6. Savill J., Mooney A., and Hughes J. Apoptosis and renal scarring. Kidney Int Suppl 54 (1996) S14-S17
7. Soto H., Mosquera J., Rodriguez-Iturbe B., Henriquez La Roche C., and Pinto A. Apoptosis in proliferative glomerulonephritis. Decreased apoptosis expression in lupus nephritis. Nephrol Dial Transplant 12 (1997) 273-280
8. Lu F.M., Shen W., Zhang X.R., Guo M.Y., and Lin S.Y. Dysregulation of apoptosis. A possible mechanism leading to chronic progressive renal histological changes in lupus nephritis. Chin Med J 113 (2000) 1082-1086
9. Wargowska-Danilewicz M., and Danilewicz M. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN I. A comparative study. J Nephrol 11 (1998) 44-49
10. Makino H., Sugiyama H., Yamasaki Y., Maeshima Y., Wada J., and Kashihara N. Glomerular cell apoptosis in human lupus nephritis. Virchows Arch 443 (2003) 67-77
11. Geske F.J., and Gerschenson L.E. The biology of apoptosis. Hum Pathol 32 (2001) 1029-1038
12. Walker J.A., and Quirke P. Viewing apoptosis through a "TUNEL.". J Pathol 195 (2000) 275-276
13. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., and Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death. A cautionary note. Hepatology 21 (1995) 1465-1468
14. Gown A.M., and Willingham M.C. Improved detection of apoptotic cells in archival paraffin sections. Immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 50 (2002) 449-454
15. Kockx M.M., Muhring J., Knaapen M.W., and de Meyer G.R. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 152 (1998) 885-888
16. Duan W.R., Garner D.S., Williams S.D., Funckes-Shippy C.L., Spath I.S., and Blomme E.A. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199 (2003) 221-228
17. Wang J.S., Tseng H.H., Shih D.F., and Ger L.P. Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis. Nephron 97 (1997) 404-411
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725-1725
19. Weening J.J., D'Agati V.D., Schwartz M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 (2004) 241-250
20. Churg J., Bernstein J., and Glassock R.J. Renal Disease. Classification and Atlas of Glomerular Diseases (1995), Igaku-Shoin, New York, NY
21. Austin H.A., Muenz L.R., Joyce K.M., Antonovych T.A., and Balow J.E. Diffuse proliferative lupus nephritis. Identification of specific pathologic features affecting renal outcome. Kidney Int 25 (1984) 689-695
22. Amore A., and Coppo R. Role of apoptosis in pathogenesis and progression of renal disease. Nephron 86 (2000) 99-104
23. Tashiro K., Kodera S., Takahashi Y., Horikoshi S., Shirato I., and Tomino Y. Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron 79 (1998) 21-27
24. Slee E.A., Adrain C., and Martin S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276 (2001) 7320-7326
25. Daemen M.A.R.C., van't Veer C., Danecker G., et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104 (1999) 541-549
26. Shihab F.S., Andoh T.F., Tanner A.M., Yi H., and Bennet W.M. Expression of apoptosis in regulatory genes in chronic cyclosporin nephrotoxicity favours apoptosis. Kidney Int 56 (1999) 2147-2159
27. Yang B., Johnson T.S., Thomas G.L., Watson P.F., Wagner B., and El Nahas A.M. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol 12 (2001) 485-495
28. Yang B., El Nahas A.M., Thomas G.L., et al. Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int 60 (2001) 1765-1776
29. Guo R., Wang Y., Minto A.W., Quigg R.J., and Cunningham P.N. Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 15 (2004) 3093-30102
30. Krajewska M., Wang H.G., Krajewski S., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57 (1997) 1605-1613
31. Rosen A., and Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases. Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6 (1999) 6-12
32. Hart S.P., Alexander K.M., and Dransfield I. Immune complexes bind preferentially to FcγRIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines. J Immunol 172 (2004) 1882-1887
33. Yang B., Johnson T.S., Haylor J.L., et al. Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int 63 (2003) 2050-2064
34. Bagavant H., Deshmukh U.S., Gaskin F., and Fu S.M. Lupus glomerulonephritis revisited 2004. Autoimmunity and end-organ damage. Scand J Immunol 60 (2004) 52-63
35. Dieker J.W.C., van der Vlag J., and Berden J.H.M. Deranged removal of apoptotic cells. Its role in the genesis of lupus. Nephrol Dial Transplant 19 (2004) 282-285
36. Seery J.P., Cattell V., and Watt F.M. Cutting edge. Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(beta-o-methyl)-fluoromethylketone. J Immunol 167 (2001) 2452-2455